PAX Neuroscience

Biotechnology

United States, Virginia

$100M to $250M

1-10

Collaborations Pharmaceuticals

Biotechnology

United States, North Carolina

$100M to $250M

1-10

Georgia Bio

Biotechnology

United States, Georgia

$100M to $250M

1-10

i2o Therapeutics

Biotechnology

United States, Massachusetts

$100M to $250M

1-10

Certified Genetool

Biotechnology

United States, California

$100M to $250M

1-10

NewLimit

Biotechnology

United States, California

$100M to $250M

1-10

Morphoceuticals

Biotechnology

United States, Massachusetts

$100M to $250M

1-10

Pow.bio

Biotechnology

United States, California

$100M to $250M

1-10

Amber Ophthalmics

Biotechnology

United States, California

$100M to $250M

1-10

BioScience Laboratory

Biotechnology

United States, New Jersey

$100M to $250M

1-10

Superluminal Medicines

Biotechnology

United States, Massachusetts

$100M to $250M

1-10

Visiox Pharmaceuticals

Biotechnology

United States, New York

$100M to $250M

1-10

BioAssayPro Consulting

Biotechnology

United States, California

$100M to $250M

1-10

Kendall Investor Relations

Biotechnology

United States, Massachusetts

$100M to $250M

1-10

Symbio Corporation

Biotechnology

United States, Oregon

$100M to $250M

1-10

Full Canvas Media

Biotechnology

United States, New Mexico

$100M to $250M

1-10

Holland AI

Biotechnology

United States, California

$100M to $250M

1-10

Cephla

Biotechnology

United States, California

$100M to $250M

1-10

NorthEast Eye Research Associates

Biotechnology

United States, Massachusetts

$100M to $250M

1-10

OG Biotech

Biotechnology

United States, Nevada

$100M to $250M

1-10